Oxynorm Instant (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxynorm Instant, is an opioid analgesic presented as a solid dosage form for oral use. It is indicated for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxynorm Instant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxynorm Instant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxynorm Instant is an opioid analgesic used in the management of pain across several clinical contexts.

- Acute postoperative pain: provides rapid relief following surgical procedures. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe traumatic injury pain: reduces intense pain after major injuries. - Chronic non‑cancer pain: used when other treatments have not achieved adequate control. - Palliative care pain: alleviates suffering in end‑of‑life situations.

Oxynorm Instant may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Constipation: reduced bowel motility leading to hard stools. - Nausea: sensation of queasiness often accompanied by an urge to vomit. - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivary flow causing oral discomfort. - Dizziness: light‑headed sensation, especially when standing quickly. - Sweating: increased perspiration without exertion.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure leading to fainting. - Opioid use disorder: risk of dependence, tolerance, and addiction. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing Oxynorm Instant, clinicians should consider several safety measures.

- Assess pain severity: confirm that opioid therapy is appropriate for the patient's level of pain. - Evaluate respiratory function: monitor for signs of respiratory depression, especially in opioid‑naïve patients. - Review medical history: identify risk factors such as substance abuse, head injury, or severe hepatic impairment. - Avoid concurrent CNS depressants: limit use of alcohol, benzodiazepines, or other sedatives. - Educate patients: provide guidance on proper use, storage, and disposal. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxynorm Instant can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Combined with other opioids: increases risk of respiratory depression and profound sedation. - Concomitant use with benzodiazepines: may cause severe CNS depression. - MAO‑inhibitors: can precipitate hypertensive crisis or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): raise oxycodone plasma levels. - CYP3A4 inducers (e.g., rifampicin): lower oxycod1e  - Anticholinergic drugs: - Antidepressants:  -      

The            """"  "" """""""""""""""""""""""""""""""""""""""""""""""""""""""""""